PUBLISHER: The Business Research Company | PRODUCT CODE: 1760444
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760444
Acellular dermal matrices (ADMs) are natural materials derived from skin tissue that undergo processing to remove all cellular components. These materials are utilized in surgical procedures to repair or replace damaged tissues. Serving as a scaffold, ADMs promote the growth and healing of new tissue. They are commonly used in procedures such as breast reconstruction and wound healing to support the regeneration of skin and soft tissues.
The primary types of acellular dermal matrices include human acellular dermal matrices, porcine acellular dermal matrices, and other source-derived acellular dermal matrices. Human acellular dermal matrices (HADMs) are biomaterials obtained from donated human skin, with all cellular components removed, leaving behind a collagen-rich structure that aids in tissue regeneration during reconstructive and surgical procedures. These products are distributed through various channels, such as direct sales, online platforms, and distributor networks. They are employed in a range of applications, including breast reconstruction, dental surgery, orthopedic surgery, wound care, and other medical procedures, with end users including hospitals, ambulatory surgical centers, specialty clinics, and research laboratories.
The acellular dermal matrices market research report is one of a series of new reports from The Business Research Company that provides acellular dermal matrices market statistics, including the acellular dermal matrices industry global market size, regional shares, competitors with the acellular dermal matrices market share, detailed acellular dermal matrices market segments, market trends, and opportunities, and any further data you may need to thrive in the acellular dermal matrices industry. This acellular dermal matrices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The acellular dermal matrices market size has grown rapidly in recent years. It will grow from $1.47 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth observed during the historic period can be attributed to the increasing incidence of breast cancer and mastectomies, growth in reconstructive and cosmetic surgeries, expanding use in hernia and orthopedic repairs, rising awareness and acceptance of biologic grafts, and a surge in trauma and accident cases.
The acellular dermal matrices market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The projected growth in the forecast period is expected to be driven by a rising demand for minimally invasive procedures, an increasing geriatric population, a growing focus on patient-specific and customizable ADM solutions, a higher number of reconstructive surgeries, and the growing prevalence of chronic conditions. Key trends anticipated for the forecast period include the integration of ADMs with minimally invasive surgeries, advancements in tissue engineering, the incorporation of stem cell therapies, the development of synthetic and hybrid ADMs, and innovations in dual-sided and meshed ADM designs.
The rising number of chronic wounds is expected to significantly drive the growth of the acellular dermal matrices market in the coming years. Chronic wounds are injuries or sores that either heal very slowly or do not heal at all, often recurring and requiring specialized treatment. The growing prevalence of these wounds is closely linked to the increasing number of individuals with diabetes. Diabetes can impair blood circulation and damage nerves, making it more difficult for the body to heal even minor cuts, which can then develop into serious and persistent wounds. Acellular dermal matrices assist in managing chronic wounds by serving as a supportive scaffold that promotes natural tissue regeneration and speeds up the healing process. For example, in July 2023, OSF HealthCare, a nonprofit healthcare organization based in the U.S., reported that 6.7 million people in the country are currently affected by chronic wounds, with this number projected to grow by 2% annually over the next ten years. Therefore, the increasing prevalence of chronic wounds is fueling the expansion of the acellular dermal matrices market.
Leading companies in the acellular dermal matrices market are focusing on product innovation by developing dual-sided grafts to improve surgical versatility and ease of use. Dual-sided acellular dermal matrices are advanced grafts designed with two functional surfaces, allowing for more flexible implantation and streamlined handling during surgery. For instance, in May 2023, AlloSource, a U.S.-based nonprofit organization that supplies allografts derived from human tissue for medical procedures, introduced AlloMend Duo Acellular Dermal Matrix (ADM). This product is designed specifically for soft tissue reconstruction, offering surgeons a dependable option for restoring and reinforcing soft tissue defects. The deep reticular dermal allograft is engineered to integrate well with surrounding tissues, providing a scaffold that encourages cellular repopulation and the regeneration of native tissue.
In March 2023, Aziyo Biologics, a U.S.-based regenerative medicine company, entered into a partnership with Sientra Inc. to broaden access to biologic solutions for soft tissue reconstruction. This collaboration focuses on increasing the availability of SimpliDerm, an acellular dermal matrix, to support procedures such as breast reconstruction. The initiative is aimed at improving access to biologic products for women undergoing reconstructive surgery. Sientra Inc. is a U.S.-based medical aesthetics company that produces silicone breast implants and other products for cosmetic and reconstructive breast procedures.
Major players in the acellular dermal matrices market are Johnson & Johnson, AbbVie Inc., Becton Dickinson and Company, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, ConvaTec Group plc, Integra LifeSciences Corporation, Conmed, Gunze Limited, MTF Biologics, Organogenesis Inc., RTI Surgical Holdings Inc., LifeNet Health, HANS BIOMED, PolyNovo Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, CG bio Inc., and Meccellis Biotech.
North America was the largest region in the acellular dermal matrices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acellular dermal matrices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the acellular dermal matrices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The acellular dermal matrices market includes sales of xenogeneic acellular dermal matrices, collagen-based acellular dermal matrices, bi-layered acellular dermal matrices, and dermal substitute products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Acellular Dermal Matrices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on acellular dermal matrices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for acellular dermal matrices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acellular dermal matrices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.